Forestier et al., 1985 - Google Patents
Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancyForestier et al., 1985
- Document ID
- 16921196980053520226
- Author
- Forestier F
- Daffos F
- Rainaut M
- Sole Y
- Amiral J
- Publication year
- Publication venue
- Thrombosis and haemostasis
External Links
Snippet
The vitamin K dependent coagulation factor activities were measured in 63 normal human fetuses from 19 to 28 weeks of pregnancy. These activities were included between 9 to 28 percent of normal adult levels. Prothrombin antigen, factor IX antigen and protein C were …
- 230000035935 pregnancy 0 title abstract description 15
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Forestier et al. | Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy | |
US5525478A (en) | Soluble thrombomodulin-based one-stage assay for vitamin-K dependent coagulation-inhibiting proteins | |
d'Angelo et al. | Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. | |
Soria et al. | A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosis | |
JP4486999B2 (en) | Kit for determining coagulation parameters | |
US5051357A (en) | Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor | |
CA2623142C (en) | Methods for a global assay of coagulation and fibrinolysis | |
JPH10508945A (en) | Diagnosis of thrombotic diseases | |
WO2002079375A1 (en) | Rapid assessment of coagulation activity in whole blood | |
Briët et al. | Molecular variant of factor VII | |
Nizzi et al. | Protein C and S deficiency | |
Fukuda et al. | Measuring tissue factor (factor III) activity in plasma. | |
Ratnoff | Hemostatic mechanisms in liver disease | |
Moalic et al. | Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newborns | |
España et al. | Assay of protein C in human plasma: comparison of amidolytic, coagulation, and immunochemical assays | |
Suarez et al. | Neonatal and maternal fibrinolysis: activation at time of birth | |
Van Wijk et al. | Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants. | |
Kaplan et al. | Molecular mechanisms of fibrinolysis in man | |
Kondo et al. | Cold Activation of Complement: I. Presence of Coagulation-Related Activator | |
Melissari et al. | Protein S and C4b‐binding protein in fetal and neonatal blood | |
Forestier et al. | Prenatal diagnosis of hemophilia by fetal blood sampling under ultrasound guidance | |
Guglielmone et al. | A Novel Functional Assay of Protein C in Human Plasma and fts Comparison with Amidolytic and Anticoagulant Assays | |
CA2039173C (en) | Factor ix chromogenic assay | |
Jacobsen | Proteolytic Capacity in Human Plasma Part I Measurement of proteolytic activity in the presence of natural inhibitors and study of the inter-individual variations | |
van Dieijenc | Use of Chromogenic Peptide Substrates in the Determination of Clotting Factors IIo VII, IX and X in Normal Plasma and in Plasma of Patients Treated with Oral Anticoagulants |